A study conducted by Michael D. Abramoff, MD, PhD, Founder and Executive Chairman of Digital Diagnostics, in collaboration with researchers from Johns Hopkins Medicine and the University of Wisconsin-Madison, has been highlighted by BlackDoctor.org. The study utilized our AI diagnostic system, LumineticsCore™, to evaluate AI’s effectiveness in diagnosing diabetes-related eye disease. Findings reveal that LumineticsCore significantly enhances access and promotes health equity, especially among underserved populations.
This AI Tool Detects Diabetic Eye Disease Faster in Black Americans